Attenuation of experimental tobramycin nephrotoxicity by ticarcillin
Open Access
- 1 June 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (6) , 897-902
- https://doi.org/10.1128/aac.27.6.897
Abstract
It is well known that in vitro the combination of carbenicillin, ticarcillin, or other antipseudomonal penicillins with gentamicin, tobramycin, or other aminoglycoside antibiotics results in the inactivation of the antibacterial activity of the aminoglycoside. To assess the influence of the in vivo interaction of tobramycin and ticarcillin on experimental nephrotoxicity, male Fischer 344 rats were given either tobramycin alone (120 mg/kg per day), tobramycin (120 mg/kg per day) and ticarcillin (250 mg/kg per day) concomitantly, or the combination of these drugs at the same doses that had been preincubated for 24 h and at the time of delivery contained but 63 and 25%, respectively, of the initial concentrations of tobramycin and ticarcillin as measured by conventional analytical procedures. Initial experiments were conducted to determine the concentrations of the antibiotics in serum achieved after administration of each test solution. After a single dose of the test solution, ticarcillin concentrations in serum were higher and more prolonged in rats given tobramycin plus ticarcillin than in rats given ticarcillin alone. After 7 days of exposure to the test solutions, inulin clearance in animals given tobramycin alone was 0.15 +/- 0.1 (mean +/- 2 standard errors) ml/min per 100 g of body weight as compared with 0.53 +/- 0.1 in rats given tobramycin and ticarcillin concomitantly, 0.59 +/- 0.1 in animals given the partially inactivated tobramycin-ticarcillin mixture, and 0.79 +/- 0.1 in control rats. Although there was some improvement in inulin clearance in the group containing tobramycin alone, the three treatment groups maintained the same rank relationship in inulin clearance through 14 days of treatment. Real histology confirmed the attenuation of tubular injury in animals given tobramycin and ticarcillin concomitantly. There was no evidence of toxicity from the presumed inactivation complexes of tobramycin-ticarcillin. These results document an in vivo protective effect of ticarcillin on experimental tobramycin nephrotoxicity.This publication has 19 references indexed in Scilit:
- Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbitsAntimicrobial Agents and Chemotherapy, 1984
- High-Pressure Liquid Chromatographic Assays for Ticarcillin in Serum and UrineJournal of Pharmaceutical Sciences, 1982
- Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failureAntimicrobial Agents and Chemotherapy, 1982
- Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancerArchives of internal medicine (1960), 1981
- Renal transport of organic acids and bases in aminoglycoside nephrotoxicityAntimicrobial Agents and Chemotherapy, 1979
- Effect of Time and Concentration Upon Interaction Between Gentamicin, Tobramycin, Netilmicin, or Amikacin and Carbenicillin or TicarcillinAntimicrobial Agents and Chemotherapy, 1979
- Protection from Gentamicin Nephrotoxicity by Cephalothin and CarbenicillinAntimicrobial Agents and Chemotherapy, 1979
- Comparative Nephrotoxicity of Aminoglycoside Antibiotics in RatsThe Journal of Infectious Diseases, 1978
- Inactivation of Gentamicin by Penicillins in Patients with Renal FailureAntimicrobial Agents and Chemotherapy, 1976
- Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-TobramycinAntimicrobial Agents and Chemotherapy, 1975